Your browser doesn't support javascript.
loading
Pazopanib and Fosbretabulin in recurrent ovarian cancer (PAZOFOS): A multi-centre, phase 1b and open-label, randomised phase 2 trial.
Morgan, Robert D; Banerjee, Susana; Hall, Marcia; Clamp, Andrew R; Zhou, Cong; Hasan, Jurjees; Orbegoso, Cecilia; Taylor, Sarah; Tugwood, Jonathan; Lyon, Alexander R; Dive, Caroline; Rustin, Gordon J S; Jayson, Gordon C.
Afiliação
  • Morgan RD; Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
  • Banerjee S; The Royal Marsden NHS Foundation Trust, London, UK.
  • Hall M; Mount Vernon Cancer Centre, Northwood, Middlesex, UK.
  • Clamp AR; Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
  • Zhou C; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester, UK.
  • Hasan J; Christie NHS Foundation Trust, Manchester, UK.
  • Orbegoso C; The Royal Marsden NHS Foundation Trust, London, UK.
  • Taylor S; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester, UK.
  • Tugwood J; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester, UK.
  • Lyon AR; Royal Brompton and Harefield NHS Foundation Trust, London, UK; Faculty of Medicine, National Heart & Lung Institute, Imperial College London, London, UK.
  • Dive C; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester, UK.
  • Rustin GJS; Mount Vernon Cancer Centre, Northwood, Middlesex, UK.
  • Jayson GC; Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. Electronic address: Gordon.Jayson@christie.nhs.uk.
Gynecol Oncol ; 156(3): 545-551, 2020 03.
Article em En | MEDLINE | ID: mdl-31932108

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Pirimidinas / Sulfonamidas / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Epitelial do Ovário Tipo de estudo: Clinical_trials / Etiology_studies Limite: Female / Humans Idioma: En Revista: Gynecol Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Pirimidinas / Sulfonamidas / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Epitelial do Ovário Tipo de estudo: Clinical_trials / Etiology_studies Limite: Female / Humans Idioma: En Revista: Gynecol Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Estados Unidos